A Benelux based Biotech company chose ASPERIS for developing the market entry strategy into the Danish biotech market.
A novel analytical instrument manufacturer, worked with ASPERIS to decide on a financing/growth plan in a yet to be defined market. After an in-depth technical survey of the technology, a market was identified. A market valuation was delivered with several growth trajectories, including impact on sales volumes. Financing options were proposed to help the entrepreneur decide between slow organic growth or Venture Capital financed acceleration.